Broken String Biosciences’ Post

⬇️⬇️⬇️⬇️ The Cell and Gene Therapy Catapult Annual Review 2024 is available 📊 📈 Some key considerations are highlighted below that are critical to the continued success of the sector. Fantastic to see key programmes within the organisations focusing on these areas. Lots of work to do in this exciting sector. #manufacturing, #automation, #digitalisation, #skills, #clinicaltrials

McKesson issued its 2024 Cell and Gene Therapy report last week. One theme was the idea that limited Centers of Excellence / Qualified Treatment Centers leads to limited awareness and access, especially in the onology space. Knowing that every report serves its own agenda, it's worth a thumb through (you know where to look for access - they want your data before you can download and I don't want to steal their thunder by posting whole report). #cgt #genetherapy #atmp #celltherapy #CAR-T

Cell and gene therapy in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth

Gain insights on our take on how we solve three main challenges in advancing cell and gene therapies to clinic. Join Qian(Sarah) Li, PhD, EMBA to learn about how #plasmid DNA serves essential roles as critical materials for cell and gene therapy applications and various key considerations including emerging methods for yield improvement, characterization and quality control. #celltherapy #genetherapy

The release of gene therapies is accelerating - up 4x since 2020. Come join us for a roundtable discussion on the two major types: AAV and ASCT. Detailed will be an exploration of development path and the impact on personalized medicine treatments. Send inquiry to info@devinebio.com to learn more on how to join us. #genetherapy #drugdiscovery #drugdevelopment #raredisease

Gain insights into the current top challenges in cell and gene therapy and their solutions from Catherine BUCHERE at this year's ESACT. Learn more about Sartorius cell and gene therapy solutions: https://sar.to/0i1cj #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy #ESACT #ESACT2024

AmplifyBio is now streamlining cell & gene therapy development with Benchling. This means faster development, fewer errors, and real-time data for researchers. Read more: https://bit.ly/4au1BFn #advancedtherapies #CGT

#Digitalization can transform the operation and performance of the cell and gene therapy manufacturing space, to the benefit of all. Read more: https://ow.ly/2Zoe50SVLf6 #CellAndGeneTherapy #Bioprocessing #RegenerativeMedicine #TherapeuticAdvancements

How is investment in the cell and gene therapy sector shaping up this year? Our data shows that through the first half of 2024, there have been over $11 billion in deals, approaching the annual total for 2023. Dive into ARM's full quarterly data on investments, clinical trials, and total developers on our website. 📊 https://lnkd.in/ebVuvmKK #cellandgenetherapy #data

Overcome challenges like tedious revalidation and costly optimization during cell and gene therapy scale-up. With scalable technologies and flexible formats, we help you avoid problems with yield and process consistency, so you can meet increasing patient demand efficiently: https://sar.to/73hd8 #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy